Ondansetron for spinal hypotension prevention

Prevention of post-spinal hypotension in cesarean delivery using ondansetron: a randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201609001761694

Enrollment

100

Registered

2016-09-02

Start date

2016-06-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Surgery cesarean sections

Interventions

normal saline

ondansetron

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: lower segment cesarean sections patients with American society of anesthesiologists (ASA) I-II

Exclusion criteria

Exclusion criteria: refusal to regional anesthesia obesity (BMI>30Kg/m2) twin pregnancies fetal malpresentations low baseline blood pressure (systolic blood pressure < 100 mmHg) cardiac co-morbidities (ASA) grading III and IV.

Design outcomes

Primary

Measure	Time frame
Post spinal hypotension in cesarean delivery	—

Secondary

Measure	Time frame
Hemodynamic variables (systolic blood pressure, diastolic blood pressure, and heart rate)	—

Countries

Egypt

Contacts

Public ContactAhmed Elsakka

Lecturer of aneasthesia Faculty of medicine Cairo university

ahmedsakka2@hotmail.com00201002414221

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026